Oral Anticoagulation Compared to Left Atrial Appendage Closure Following Catheter Ablation: Results From the OPTION Trial

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Innhold levert av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

20d ago 19:47

MP3•Episoder hjem

A Cleveland Clinic-led trial found that a minimally-invasive procedure – left atrial appendage closure (LAAC) – resulted in significantly less bleeding in patients undergoing a catheter ablation to treat atrial fibrillation, compared to oral anticoagulation, while preserving low rates of stroke, blood clots and death. The OPTION Trial was presented at the American Heart Association’s Scientific Sessions 2024. Walid Saliba, MD speaks with Oussama Wazni, MD, Section Head of Cardiac Electrophysiology and Pacing at Cleveland Clinic and Primary Investigator of the OPTION Trial, about the results of the trial and implications for practice.
Learn more about the Atrial Fibrillation Stroke Prevention Center
https://my.clevelandclinic.org/departments/heart/depts/atrial-fibrillation-stroke-prevention-center
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ext. 49162

301 episoder

#Fitness #Cardiac Consult: For Healthcare Professionals #Cleveland Clinic #Vascular Institute #Cleveland Clinic Heart #Health Industry #Health and Well-Being #Health Care